Representative tissue specimens were embedded in paraffin, sectioned at 4 m, stained with hematoxylin and eosin (H&E), and evaluated by light microscopy using an Olympus 71 digital camera and an Olympus BX51 microscope (Japan) acquiring digital images saved as uncompressed 24-bit RGB TIFF files
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday
doi: 10.3390/nu15092150 242 AkbaralyTNBrunnerEJFerrieJEMarmotMGKivimakiMSingh-ManouxA
BPC-157 UK is not MHRA or FDA approved for clinical use
Avoid Smoking and Alcohol: Quitting smoking and alcohol consumption can reduce the risk of Barrett's esophagus and its progression